DeepMed Research

M-1231

Generic Name: M-1231

Clinical Trials

M1231 in Participants With Solid Tumors

Phase 1

Completed

Conditions: Metastatic Solid Tumors
Non-Small Cell Lung Cancer
Esophageal Cancer

Interventions: Drug: M1231

First Posted Date: 2021-01-05

Last Posted Date: 2023-07-07

Lead Sponsor: EMD Serono Research & Development Institute, Inc.

Target Recruit Count: 23

Registration Number: NCT04695847

Locations: 🇺🇸
MD Anderson Cancer Center - Clinical Cancer Prevention, Houston, Texas, United States
🇨🇦
Princess Margaret Cancer Centre, Toronto, Canada
🇺🇸
NEXT Oncology, San Antonio, Texas, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy